The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis
- 15 February 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (4) , 1699-1705
- https://doi.org/10.1182/blood-2004-06-2485
Abstract
Idiopathic myelofibrosis (IM) is characterized by the constitutive mobilization of CD34+ cells. IM peripheral blood (PB) CD34+ cells had a reduced cloning efficiency and a lower frequency of cobblestone areas compared with normal granulocyte colony-stimulating factor (G-CSF)-mobilized PB CD34+ cells. IM CD34+ cells engrafted nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice, demonstrating that they contain bone marrow (BM)-repopulating cells. G-CSF-mobilized CD34+ cells produced multiple hematopoietic lineages within the NOD/SCID mice with a predominance of CD19+ cells. By contrast, IM CD34+ cells produced predominantly CD33+ cells, increased numbers of CD41+ cells, but fewer CD19+ cells. Transcriptional clonality assays of the engrafted human IM cells demonstrated their clonal origin. CD34+ cells from one patient isolated prior to leukemic transformation were capable of generating acute leukemia in NOD/SCID mice. The engrafted human cells exhibited the same abnormal karyotype as primary cells in a portion of the population. These findings demonstrate that BM-repopulating cells and more differentiated progenitor cells are constitutively mobilized into the PB in IM, and that their differentiation program is abnormal. In addition, the NOD/SCID model may be useful in gaining an understanding of the events occurring during the transition of IM to acute leukemia. (Blood. 2005;105:1699-1705)Keywords
This publication has 31 references indexed in Scilit:
- Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosisEuropean Journal of Haematology, 2009
- Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndromeBlood, 2004
- Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin ABlood, 2004
- Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?Blood, 2003
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Cellular and Molecular Aspects of Human CD34+ CD38-Precursors: Analysis of a Primitive Hematopoietic PopulationLeukemia & Lymphoma, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Phenotypic Analysis and Characterization of CD34+ Cells from Normal Human Bone Marrow, Cord Blood, Peripheral Blood, and Mobilized Peripheral Blood from Patients Undergoing Autologous Stem Cell TransplantationClinical Immunology and Immunopathology, 1994
- Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblastsBritish Journal of Haematology, 1988
- Translocation (3;21) in Philadelphia chromosome—positive chronic myelogenous leukemia prior to the onset of blast crisisAmerican Journal of Hematology, 1988